Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration
โ Scribed by W. H. Aellig; J. Rosenthaler
- Publisher
- Springer
- Year
- 1986
- Tongue
- English
- Weight
- 320 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Dichlorazepate (DPC) was given to eight healthy volunteers aged 22-38 years (five males and three females). The dose was 20 mg (48.9 gmol) given either as an IV or an IM injection. The interval between the injections was at least 1 week. Plasma samples were analysed for desmethyldiazepam (DMD) by HP
Toxogonin, given intramuscularly to 10 healthy young pralidoxime (chloride and methanesulfonate) suggest further inmen in doses of 2.5-10 mg./kg., produced dose-related oxime whole quiry into toxogonin's therapeutic potential may be needed. blood levels of 6.3-26.5 mcg./ml. and hada plasma half-time
This study was conducted to determine the uptake of dihydroergotamine (DHE) into the brain after intravenous and intranasal administration in rats. Eight anesthetized rats received either an intravenous (i.v.) or two successive intranasal (i.n.) doses of tritium labeled dihydroergotamine ( 3 H-DHE)